{"id": "article-40627_0", "title": "Drug Enforcement Administration Drug Scheduling -- Definition/Introduction", "content": "Drug scheduling became mandated under The Federal Comprehensive Drug Abuse Prevention and Control Act of 1970 (also known as the Controlled Substances Act).\u00a0The\u00a0law addresses controlled substances within Title II.\u00a0Based upon this law, the United States Drug Enforcement Agency (DEA) maintains a list of controlled medications and illicit substances categorized from Schedule I to V. [1]", "contents": "Drug Enforcement Administration Drug Scheduling -- Definition/Introduction. Drug scheduling became mandated under The Federal Comprehensive Drug Abuse Prevention and Control Act of 1970 (also known as the Controlled Substances Act).\u00a0The\u00a0law addresses controlled substances within Title II.\u00a0Based upon this law, the United States Drug Enforcement Agency (DEA) maintains a list of controlled medications and illicit substances categorized from Schedule I to V. [1]"}
{"id": "article-40627_1", "title": "Drug Enforcement Administration Drug Scheduling -- Definition/Introduction", "content": "The five categories have their basis on the medication\u2019s proper and beneficial medical use and the medication\u2019s potential for dependency and misuse or abuse. The purpose of the law is to provide government oversight\u00a0over the manufacturing and distribution of these substances. Prescribers and dispensers are required to have a DEA license to supply these drugs. The licensing provides links to users, prescribers, and distributors. [2] [3]", "contents": "Drug Enforcement Administration Drug Scheduling -- Definition/Introduction. The five categories have their basis on the medication\u2019s proper and beneficial medical use and the medication\u2019s potential for dependency and misuse or abuse. The purpose of the law is to provide government oversight\u00a0over the manufacturing and distribution of these substances. Prescribers and dispensers are required to have a DEA license to supply these drugs. The licensing provides links to users, prescribers, and distributors. [2] [3]"}
{"id": "article-40627_2", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern", "content": "The schedules range from Schedule I to V. Schedule I drugs are considered to have the highest risk of abuse, with no recognized medical use in the US, while Schedule V drugs have the lowest potential for abuse. Other factors considered by the DEA include pharmacological effect, evidenced-based knowledge of the drug, the risk to public health, trends in the use of the drug, and whether or not the drug has the potential to be made more dangerous with minor chemical modifications.", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern. The schedules range from Schedule I to V. Schedule I drugs are considered to have the highest risk of abuse, with no recognized medical use in the US, while Schedule V drugs have the lowest potential for abuse. Other factors considered by the DEA include pharmacological effect, evidenced-based knowledge of the drug, the risk to public health, trends in the use of the drug, and whether or not the drug has the potential to be made more dangerous with minor chemical modifications."}
{"id": "article-40627_3", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule I:", "content": "\"High abuse potential with no accepted medical use; medications within this schedule may not be prescribed, dispensed, or administered\" [1] Examples include marijuana (cannabis), heroin, mescaline (peyote), lysergic acid\u00a0diethylamide (LSD), methylenedioxymethamphetamine (MDMA), and methaqualone.", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule I:. \"High abuse potential with no accepted medical use; medications within this schedule may not be prescribed, dispensed, or administered\" [1] Examples include marijuana (cannabis), heroin, mescaline (peyote), lysergic acid\u00a0diethylamide (LSD), methylenedioxymethamphetamine (MDMA), and methaqualone."}
{"id": "article-40627_4", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule II:", "content": "\"High abuse potential with severe psychological or physical dependence; however, these medications have an accepted medical use and may be prescribed, dispensed, or administered\" [1] Examples include\u00a0fentanyl, oxycodone, morphine, methylphenidate, hydromorphone, amphetamine, methamphetamine (\"meth\"), pentobarbital,\u00a0and secobarbital. Schedule II drugs may not receive a refill at the pharmacy", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule II:. \"High abuse potential with severe psychological or physical dependence; however, these medications have an accepted medical use and may be prescribed, dispensed, or administered\" [1] Examples include\u00a0fentanyl, oxycodone, morphine, methylphenidate, hydromorphone, amphetamine, methamphetamine (\"meth\"), pentobarbital,\u00a0and secobarbital. Schedule II drugs may not receive a refill at the pharmacy"}
{"id": "article-40627_5", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule III:", "content": "\"Intermediate abuse potential (ie, less than Schedule II but more than Schedule IV medications)\" [1] examples include anabolic steroids, testosterone, and ketamine", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule III:. \"Intermediate abuse potential (ie, less than Schedule II but more than Schedule IV medications)\" [1] examples include anabolic steroids, testosterone, and ketamine"}
{"id": "article-40627_6", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule IV:", "content": "\"Abuse potential less than Schedule II but more than Schedule V medications\" [1] Examples include diazepam, alprazolam, and tramadol", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule IV:. \"Abuse potential less than Schedule II but more than Schedule V medications\" [1] Examples include diazepam, alprazolam, and tramadol"}
{"id": "article-40627_7", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule V:", "content": "\"Medications with the least potential for abuse among the controlled substances.\" [1] Examples include pregabalin, diphenoxylate/atropine, dextromethorphan", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern -- Schedule V:. \"Medications with the least potential for abuse among the controlled substances.\" [1] Examples include pregabalin, diphenoxylate/atropine, dextromethorphan"}
{"id": "article-40627_8", "title": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern", "content": "Only Drug Enforcement Administration (DEA) registered practitioners can prescribe controlled substances. All prescriptions for Schedule II medications must be\u00a0provided to the pharmacist in written form or transmitted by an approved computer system for electronic prescribing of controlled substances (EPCS). Several states now require EPCS systems to be used for controlled substance prescribing. A prescription for a Schedule II medication may be called in by a registered practitioner in an emergency; however, a written prescription must\u00a0be provided within 7 days. [3] Note the following tables for additional information on DEA drug schedules: Table 1: Information regarding registration, records, prescriptions, refills, distribution, security, and theft or significant loss of controlled substances. Table 2: Information regarding DEA forms 106, 222, 224, and 224a.", "contents": "Drug Enforcement Administration Drug Scheduling -- Issues of Concern. Only Drug Enforcement Administration (DEA) registered practitioners can prescribe controlled substances. All prescriptions for Schedule II medications must be\u00a0provided to the pharmacist in written form or transmitted by an approved computer system for electronic prescribing of controlled substances (EPCS). Several states now require EPCS systems to be used for controlled substance prescribing. A prescription for a Schedule II medication may be called in by a registered practitioner in an emergency; however, a written prescription must\u00a0be provided within 7 days. [3] Note the following tables for additional information on DEA drug schedules: Table 1: Information regarding registration, records, prescriptions, refills, distribution, security, and theft or significant loss of controlled substances. Table 2: Information regarding DEA forms 106, 222, 224, and 224a."}
{"id": "article-40627_9", "title": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance", "content": "Medications are routinely added to the list and can be moved from one category to another as our knowledge and understanding of the medications advance. The DEA maintains a current list on its website under the diversion control division heading. Prescribers may prescribe Schedule II through V medications as allowed by their DEA and state-controlled substance or medical license.", "contents": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance. Medications are routinely added to the list and can be moved from one category to another as our knowledge and understanding of the medications advance. The DEA maintains a current list on its website under the diversion control division heading. Prescribers may prescribe Schedule II through V medications as allowed by their DEA and state-controlled substance or medical license."}
{"id": "article-40627_10", "title": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance", "content": "Not all prescribers are licensed to prescribe all levels of controlled substances as their individual state or DEA licenses limit some,\u00a0and\u00a0other practitioners are under limitations by their professions, such as advanced practice providers in many states. The prescriber\u00a0and the dispensing pharmacist are responsible for knowing\u00a0each medication's category and ensuring that only properly licensed individuals prescribe the medications. Healthcare practitioners must understand the DEA controlled-substance scheduling to exercise appropriate caution when prescribing medications with high abuse potential and to ensure against prescribing outside of one's authority. [4] [5]", "contents": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance. Not all prescribers are licensed to prescribe all levels of controlled substances as their individual state or DEA licenses limit some,\u00a0and\u00a0other practitioners are under limitations by their professions, such as advanced practice providers in many states. The prescriber\u00a0and the dispensing pharmacist are responsible for knowing\u00a0each medication's category and ensuring that only properly licensed individuals prescribe the medications. Healthcare practitioners must understand the DEA controlled-substance scheduling to exercise appropriate caution when prescribing medications with high abuse potential and to ensure against prescribing outside of one's authority. [4] [5]"}
{"id": "article-40627_11", "title": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance", "content": "The Controlled Substances Act has\u00a0significant potential to improve patient safety by providing federal\u00a0oversight\u00a0for drugs with\u00a0a high potential for misuse and abuse. Prescribers of scheduled substances (physicians, dentists, podiatrists, advanced practitioners) may have links to the distribution of these substances. These practitioners are required to have a DEA license and record prescriptions of scheduled drugs. This licensing prevents overprescribing and obligates providers to\u00a0be wary of potential drug-seeking patients.", "contents": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance. The Controlled Substances Act has\u00a0significant potential to improve patient safety by providing federal\u00a0oversight\u00a0for drugs with\u00a0a high potential for misuse and abuse. Prescribers of scheduled substances (physicians, dentists, podiatrists, advanced practitioners) may have links to the distribution of these substances. These practitioners are required to have a DEA license and record prescriptions of scheduled drugs. This licensing prevents overprescribing and obligates providers to\u00a0be wary of potential drug-seeking patients."}
{"id": "article-40627_12", "title": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance", "content": "The dispenser\u00a0must also be aware of\u00a0a patient's medication history and be mindful of the potential for polypharmacy if a patient seeks\u00a0multiple providers. The current opioid epidemic is a time where\u00a0federal oversight and interdisciplinary coordination have the potential to reduce harm to patients prescribed scheduled drugs drastically. However, this change will take additional time and evaluation to determine if drug scheduling reduces misuse, abuse, addiction, and overdose. [6] [7] [8] [9] [10]", "contents": "Drug Enforcement Administration Drug Scheduling -- Clinical Significance. The dispenser\u00a0must also be aware of\u00a0a patient's medication history and be mindful of the potential for polypharmacy if a patient seeks\u00a0multiple providers. The current opioid epidemic is a time where\u00a0federal oversight and interdisciplinary coordination have the potential to reduce harm to patients prescribed scheduled drugs drastically. However, this change will take additional time and evaluation to determine if drug scheduling reduces misuse, abuse, addiction, and overdose. [6] [7] [8] [9] [10]"}
{"id": "article-40627_13", "title": "Drug Enforcement Administration Drug Scheduling -- Nursing, Allied Health, and Interprofessional Team Interventions", "content": "The healthcare team,\u00a0comprised of physicians, advanced practice practitioners, nurses, pharmacists, etc,\u00a0must work together to address the proper medical use of controlled substances\u00a0for pain control via pharmacotherapy. The healthcare team should schedule their patients for routine follow-up visits, including a history and physical exam, to monitor for adverse drug effects and misuse. It is also important to ensure these measures to limit controlled substances do not impair the ability of patients to obtain these medications when there is a legitimate medical need.", "contents": "Drug Enforcement Administration Drug Scheduling -- Nursing, Allied Health, and Interprofessional Team Interventions. The healthcare team,\u00a0comprised of physicians, advanced practice practitioners, nurses, pharmacists, etc,\u00a0must work together to address the proper medical use of controlled substances\u00a0for pain control via pharmacotherapy. The healthcare team should schedule their patients for routine follow-up visits, including a history and physical exam, to monitor for adverse drug effects and misuse. It is also important to ensure these measures to limit controlled substances do not impair the ability of patients to obtain these medications when there is a legitimate medical need."}
{"id": "article-40627_14", "title": "Drug Enforcement Administration Drug Scheduling -- Nursing, Allied Health, and Interprofessional Team Interventions", "content": "Monitoring for signs of drug misuse is a critical responsibility for the healthcare team because of the epidemic rates of drug misuse worldwide,\u00a0particularly in the USA, which leads to death because of respiratory depression as in the case of opioid analgesic overdose (eg, oxycodone, fentanyl). Methods for monitoring drug abuse as well as drug diversion include the following examples: assessment surveys, state prescription drug monitoring programs, urine screening, adherence checklists, motivational counseling, and dosage form counting. [Level 5]", "contents": "Drug Enforcement Administration Drug Scheduling -- Nursing, Allied Health, and Interprofessional Team Interventions. Monitoring for signs of drug misuse is a critical responsibility for the healthcare team because of the epidemic rates of drug misuse worldwide,\u00a0particularly in the USA, which leads to death because of respiratory depression as in the case of opioid analgesic overdose (eg, oxycodone, fentanyl). Methods for monitoring drug abuse as well as drug diversion include the following examples: assessment surveys, state prescription drug monitoring programs, urine screening, adherence checklists, motivational counseling, and dosage form counting. [Level 5]"}
{"id": "article-40627_15", "title": "Drug Enforcement Administration Drug Scheduling -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Drug Enforcement Administration Drug Scheduling -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}